http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102961336-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aee739903a8ffe4df1a67e8dd992cf44 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c142aa8363bd9d19759b7022528a4dc2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2d440b47e2886712009611bd21b6dc1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd2d644ad34091921bb39e8f2e73fa36 |
publicationDate | 2014-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-102961336-B |
titleOfInvention | Nanoscale platinum drug and preparation method thereof |
abstract | The invention discloses a nanoscale platinum drug and a preparation method thereof, relating to an anti-tumor platinum drug. In allusion to the defects that the platinum drugs are low in solubility and low in biological utilization rate of oral administration and the existing platinum drug injections have server toxic and side effects, the invention firstly aims at providing a novel nanoscale platinum drug particle which is characterized by taking silicon dioxide aerogel as a carrier of the platinum drug; and the invention secondly aims at providing a preparation method of the novel nanoscale platinum drug particle; and the preparation method is characterized by comprising the steps of: dissolving the platinum drug in a 1.5%(W/V) Nacl solution, adding the silicon dioxide aerogel according to proportion, drying after complete adsorption, adding purified water and sending into an emulsifying machine for emulsification, homogenizing through a high-pressure homogenizer, and drying the obtained homogenate to obtain the nanoscale platinum drug particle. The nanoscale platinum drug provided by the invention is particularly suitable for oral administration. |
priorityDate | 2012-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.